NCT05282394

Brief Summary

The proposed study will incorporate an intervention previously un-studied in the US healthcare setting for prevention of hyperbilirubinemia

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Aug 2022Jun 2026

First Submitted

Initial submission to the registry

December 14, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 16, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Last Updated

September 19, 2025

Status Verified

September 1, 2025

Enrollment Period

3.9 years

First QC Date

December 14, 2021

Last Update Submit

September 18, 2025

Conditions

Keywords

newborn massage

Outcome Measures

Primary Outcomes (2)

  • Acceptability of the newborn massage intervention

    Acceptability of the intervention will be defined by the 1-sided 95% confidence interval for the proportion of the intervention group performing massage at least once to include 80% and for the 1-sided 95% confidence interval for at the proportion performing massage as directed to include 70%.

    Through study completion, up to one year

  • Feasibility of recruitment

    Feasibility of recruitment will be defined by at least 30% of approached, eligible participants consenting to participate.

    Ascertained following completion of recruitment of 30 study participants. Through study completion, up to an average of one year.

Secondary Outcomes (7)

  • Difference between transcutaneous bilirubin level and AAP phototherapy threshold on the day of discharge

    Value at obtained at hospital discharge will be evaluated at the end of study completion, up to one year

  • Number of stools in prior 24 hours (at hospital discharge)

    Value at obtained at hospital discharge will be evaluated at the end of study completion, up to one year

  • Timing of first transitional (non-meconium) stool passage

    Ascertained at 1-2 week survey

  • Parental satisfaction with newborn massage

    7-14 day survey

  • Proportion of participants who read with baby in the last 24 hours

    1-2 week survey

  • +2 more secondary outcomes

Study Arms (2)

Massage Intervention

EXPERIMENTAL

Families will be instructed to provide parent-provided newborn abdominal massage three times per day through 5 days of life

Procedure: Abdominal massage

Attention Control Intervention

OTHER

Families will be provided with information about reading with baby.

Other: Reading

Interventions

abdominal massage

Massage Intervention
ReadingOTHER

guidance given to parents about reading with baby

Attention Control Intervention

Eligibility Criteria

Age0 Hours - 48 Hours
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Newborn admitted to the well newborn/postpartum care unit at UC Davis Medical Center
  • Less than 48 hours of age at enrollment

You may not qualify if:

  • Infant has already received phototherapy
  • Mother/birthing person is incarcerated
  • Infant unexpected to discharge into parental care
  • Parental inability to speak or read in English
  • Infant without parent rooming-in with them in the hospital

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California-Davis

Sacramento, California, 95817, United States

Location

MeSH Terms

Conditions

Jaundice, Neonatal

Condition Hierarchy (Ancestors)

Hyperbilirubinemia, NeonatalInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHyperbilirubinemiaPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Laura Kair, MD, MAS

    UC Davis Health

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2021

First Posted

March 16, 2022

Study Start

August 1, 2022

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

September 19, 2025

Record last verified: 2025-09

Locations